These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


853 related items for PubMed ID: 6233369

  • 1. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ, van Krimpen BA, Ronteltap CP, Bolhuis RL.
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [Abstract] [Full Text] [Related]

  • 2. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
    van de Griend RJ, Giphart MJ, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
    [Abstract] [Full Text] [Related]

  • 3. A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity.
    Roberts K, Moore M.
    Eur J Immunol; 1985 May; 15(5):448-56. PubMed ID: 3873338
    [Abstract] [Full Text] [Related]

  • 4. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M.
    J Immunol; 1984 Jun 01; 132(6):2775-82. PubMed ID: 6202760
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic characteristics of human natural killer cells.
    Perussia B, London L, Trinchieri G.
    Biomed Pharmacother; 1985 Jun 01; 39(1):13-8. PubMed ID: 3875369
    [Abstract] [Full Text] [Related]

  • 11. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE, Hercend T, Fox DA, Bensussan A, Bartley G, Daley JF, Schlossman SF, Reinherz EL, Ritz J.
    J Immunol; 1985 Jul 01; 135(1):672-8. PubMed ID: 3923116
    [Abstract] [Full Text] [Related]

  • 12. Ultrastructural characteristics of human T cell clones with various cytolytic activities.
    Grossi CE, Zicca A, Cadoni A, Mingari MC, Moretta A, Moretta L.
    Eur J Immunol; 1983 Aug 01; 13(8):670-7. PubMed ID: 6224698
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S, Miescher S, Zocchi MR, von Fliedner V, Moretta A.
    J Immunol; 1987 Feb 15; 138(4):1297-302. PubMed ID: 3100633
    [Abstract] [Full Text] [Related]

  • 15. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M, Williams PS, Solomon SD, Rubin AL, Stenzel KH.
    J Clin Invest; 1984 Dec 15; 74(6):2263-71. PubMed ID: 6392343
    [Abstract] [Full Text] [Related]

  • 16. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
    Moretta A, Pantaleo G, Lopez-Botet M, Carrel S, Moretta L.
    Behring Inst Mitt; 1985 Aug 15; (77):39-47. PubMed ID: 2417584
    [Abstract] [Full Text] [Related]

  • 17. Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures.
    Moretta A, Pantaleo G, Mingari MC, Melioli G, Moretta L, Cerottini JC.
    Eur J Immunol; 1984 Feb 15; 14(2):121-5. PubMed ID: 6230242
    [Abstract] [Full Text] [Related]

  • 18. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 19. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R, Handa K, Itoh K, Kumagai K.
    J Immunol; 1983 Feb 01; 130(2):981-7. PubMed ID: 6600260
    [Abstract] [Full Text] [Related]

  • 20. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A.
    Eur J Immunol; 1995 Feb 01; 25(2):369-76. PubMed ID: 7875198
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 43.